Systemic ionic and metabolic homeostasis

Systemic ionic and metabolic homeostasis describes the dynamic equilibrium that organisms maintain to keep the levels of key ions (such as sodium, potassium, calcium) and metabolic intermediates within narrow ranges essential for survival[1][2][3][5]. This process is governed by complex interdependent regulatory networks involving ion channels, transporters, enzymes, organ systems (e.g., kidneys, cardiovascular system), and signaling pathways. These networks detect deviations from optimal internal conditions and initiate corrective adaptations via feedback mechanisms. Disease frequently results from persistent disruption of ionic or metabolic homeostasis, including cancer (where irregular sodium and metabolic control promote unchecked proliferation)[2], metabolic syndromes (e.g., diabetes), and cardiovascular disorders[3]. In drug development, compounds rarely target "systemic homeostasis" itself; instead, they modulate specific components or regulators (e.g., ion channels, metabolic enzymes, receptors) that participate in maintaining this balance. While systemic homeostasis is critical for organismal viability, it is a high-level biological process, not a well-defined drug target.\n\nThis entry is not suitable as a drug target record because it describes a physiological state maintained by many interrelated molecules and systems, not a single target amenable to pharmacological intervention[1][2][3][5].

Other names

systemic homeostasisionic homeostasismetabolic homeostasis